NOVARTIS AG (NVSEF)
Clinical trial NCT06331312 updates: 1. completion date: 2028-08-22 → 2028-05-08 2. primary completion date: 2028-08-22 → 2028-05-08
Clinical trial NCT06331312 updates: 1. completion date: 2028-08-22 → 2028-05-08 2. primary completion date: 2028-08-22 → 2028-05-08
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical